Determining the pneumococcal conjugate vaccine coverage required for indirect protection within Asia and the Pacific: a prospective observational study

Background: Pneumococcal disease is an important cause of childhood morbidity and mortality worldwide. Evidence is required to support the introduction of pneumococcal conjugate vaccines (PCVs) in low-income and middle-income countries (LMICs). PCVs prevent disease through both direct protection of...

Full description

Bibliographic Details
Main Authors: Jocelyn Chan, MBBS, Jana Y Lai, BScK, Claire von Mollendorf, PhD, Christopher Blyth, PhD, David A B Dance, FRCPath, Siddhartha Datta, MD, Eileen M Dunne, PhD, Rebecca Ford, PhD, Kimberley Fox, MD, Jason Hinds, PhD, Keoudomphone Vilivong, MD, Sophie La Vincente, PhD, Deborah Lehmann, MBBS, Kerryn A Moore, PhD, Tuya Mungun, MD, Monica L Nation, MEpi, Paul N Newton, MRCP, Cattram D Nguyen, PhD, William Pomat, PhD, Anonh Xeuatvongsa, PhD, Catherine Satzke, PhD, E Kim Mulholland, MD, Fiona M Russell, PhD
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X19301007